✦ LIBER ✦

Weekly paclitaxel, cisplatin, and radiation in advanced head and neck cancer (AHNC)

✍ Scribed by Anand K. Sharma; Kim Vu; Terry A. Day; Marion Boyd Gillespie; Serap Koybasi; Robert K. Stuart

Book ID: 116809897
Publisher: SAGE Publications
Year: 2004
Tongue: English
Weight: 42 KB
Volume: 131
Category: Article
ISSN: 0194-5998
DOI: 10.1016/j.otohns.2004.06.460

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Concomitant weekly cisplatin and altered

Concomitant weekly cisplatin and altered fractionation radiotherapy in locally advanced head and neck cancer

✍ Heather E. Newlin; Robert J. Amdur; Charles E. Riggs; Christopher G. Morris; Jes 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 2 views

## Abstract ## BACKGROUND: Both concomitant chemotherapy and altered fractionation radiotherapy (RT) have been shown to improve outcomes for patients with locoregionally advanced head and neck squamous cell carcinomas. However, both strategies also increase acute toxicity, and it is questionable w

Phase II study paclitaxel (PTX) and cisp

Phase II study paclitaxel (PTX) and cisplatin (Cis) in advanced and recurrent head&neck cancer

✍ V. Adamo; R. Maisano; A. Laudani; G. Altavilla; N. Caristi; A. D'Angelo; G. Ferr 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Chemoradiation in Advanced Head and Neck

Chemoradiation in Advanced Head and Neck Cancers: A Comparison of two Radiosensitizers, Paclitaxel and Cisplatin

✍ Sohit Paul Kanotra; Sonika Kanotra; Ashutosh Gupta; J. Paul 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 237 KB

Hyperfractionated accelerated radiothera

Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer

✍ Gabriele K. Beckmann; Florian Hoppe; Leo Pfreundner; Michael P. Flentje 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 267 KB 👁 2 views

## Background: The purpose of this study was to determine the feasibility and efficacy of hyperfractionated accelerated radiotherapy (hfrcb) combined with simultaneous chemotherapy with weekly cisplatin (cddp) in locally advanced inoperable head and neck cancer. ## Methods: From august 1999 to de

High-dose cisplatin in advanced head and

High-dose cisplatin in advanced head and neck cancer

✍ Arlene A. Forastiere; Bonnie J. Takasugi; Shan R. Baker; Gregory T. Wolf; Vickie 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 452 KB

In 22 patients with advanced squamous cell carcinoma of the head and neck we evaluated the efficacy and toxicity of 200 mg/m2 cisplatin administered in 3% NaCl with vigorous hydration. Six patients had previously untreated stage IV disease and 16 patients had recurrent disease, including eight with

Cisplatin-containing chemotherapy in adv

Cisplatin-containing chemotherapy in advanced head and neck cancer

✍ I.C.M. Paterson; P.M. Quilty 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 409 KB